Vaseretic Related Published Studies
Well-designed clinical trials related to Vaseretic (Enalapril / Hydrochlorothiazide)
Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension. [2006.01]
Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial. [2004.09]
Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients. [2004.03]
Evaluation of the bioequivalence of two tablet formulations of enalapril/hydrochlorothiazide after single oral administration to healthy volunteers. [2004]
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. [2003.10.14]
Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms. [2003.06]
Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study. [2002.11]
Comparative bioavailability of two immediate release tablets of enalapril/hydrochlorothiazide in healthy volunteers. [2002.04]
Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension. [2001.12]
Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial. [2001.09.11]
Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide. [2000.05]
Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. [2000.05]
Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. Eprosartan Study Group. [1999.06]
Lisinopril versus enalapril: evaluation of trough:peak ratio by ambulatory blood pressure monitoring. [1999.06]
The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension. [1999.04]
Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group. [1999.02]
Effect of eprosartan and enalapril in the treatment of black hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group. [1999]
Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group. [1999]
Effect of eprosartan and enalapril in the treatment of elderly hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group. [1999]
Combination of enalapril and low-dose thiazide reduces normoalbuminuria in essential hypertension. [1998.10]
Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies. [1998.09]
Efficacy of low-dose combination of bisoprolol/hydrochlorothiazide compared with amlodipine and enalapril in men and women with essential hypertension. [1998.06.01]
Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Study Group. [1998.05]
Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group. [1997.08]
Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group. [1997.07.19]
Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patients. [1996.07]
Comparison of captopril-thiazide and enalapril-thiazide combinations in the management of mild to moderate black hypertensive patients: how important is diuretic dose and duration of action of the ACE-inhibitor? [1996.06]
Quality of life in hypertensive patients treated with either carvedilol or enalapril. [1996.01]
[Double blind randomized comparative study of two antihypertensive combinations. Enalapril-hydrochlorothiazide versus enalapril-nifedipine in 240 hypertensive patients resistant to monotherapy] [1996.01]
Effect of hydrochlorothiazide on the pharmacokinetics of enalapril in hypertensive patients with varying renal function. [1996.01]
An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension. [1995.12]
Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension. [1995.09]
The efficacy and tolerability of enalapril in a formulation with a very low dose of hydrochlorothiazide in hypertensive patients resistent to enalapril monotherapy. [1995.07]
Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril. [1995.06]
[Comparison of the efficacy of enalapril + hydrochlorothiazide and captopril + hydrochlorothiazide combinations in mild-to-moderate arterial hypertension by ambulatory measurement of blood pressure] [1995.05]
Relationship between change in erythrocyte sodium and antihypertensive response to enalapril. [1994.11]
Effectiveness of enalapril in combination with low-dose hydrochlorothiazide versus enalapril alone for mild to moderate systemic hypertension in black patients. [1994.06.01]
A long-term, double-blind, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study. [1994.05]
Effects of diltiazem, metoprolol, enalapril and hydrochlorothiazide on frequency of ventricular premature complexes. [1994.02.01]
Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women. [1994.01]
The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide. [1993.09]
Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group. [1993.04.01]
Effect of hydrochlorothiazide, enalapril, and propranolol on quality of life and cognitive and motor function in hypertensive patients. [1993.04]
Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes. [1993.01.16]
Enalapril versus atenolol in the treatment of hypertensive smokers. [1993]
[Antihypertensive effectiveness of enalapril and hydrochlorothiazide as a combination drug] [1993]
Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide. [1992.12]
Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension. [1992.11.15]
The efficacy of hydrochlorothiazide, timolol and enalapril in Ethiopians with essential hypertension. [1992.07]
The influence of hydrochlorothiazide on the pharmacokinetics of enalapril in elderly patients. [1992]
Comparisons of once-daily nilvadipine with enalapril and diuretic in patients with essential hypertension. [1992]
Effects of hydrochlorothiazide, diltiazem and enalapril on mononuclear cell sodium and magnesium levels in systemic hypertension. [1991.11.15]
Pharmacokinetic comparison of a combination tablet of enalapril and hydrochlorothiazide with enalapril and hydrochlorothiazide tablets administered together and separately. [1991.08]
[Comparative study of enalapril, hydrochlorothiazide and their combination in the treatment of essential hypertension] [1991.01]
Comparison of the antihypertensive effects of delapril and enalapril. [1991.01]
Treatment of essential hypertension in Asians: enalapril as monotherapy versus combination therapy with hydrochlorothiazide. [1991]
Quality of life among hypertensive patients with a diuretic background who are taking atenolol and enalapril. [1990.10]
Enalapril and nifedipine in the treatment of mild to moderate essential hypertension: a 6 month comparison. [1990.08]
[Hypertensive hypertrophy of the left ventricle: its regression in hypertensive patients with different profiles of plasma renin activity, treated with enalapril] [1990.06]
Treatment of hypertension by enalapril and hydrochlorothiazide separately and together: a multicenter study. [1990.02]
[A randomized double-blind therapeutic trial of enalapril versus timed-release nifedipine in mild to moderate essential hypertension] [1990.01.06]
Comparative efficacy and safety of enalapril and sustained-release nifedipine in patients with mild to moderate hypertension. The Enalapril vs Nifedipine French Study Group. [1990]
A randomised double blind comparison of enalapril versus hydrochlorothiazide in elderly hypertensives. [1989.04]
Comparison of increase in the enalapril dose and addition of hydrochlorothiazide as second-step treatment of hypertensive patients not controlled by enalapril alone. [1989.02]
Enalapril and hydrochlorothiazide in hypertensive Africans. [1989]
Comparative evaluation of enalapril and hydrochlorothiazide in elderly patients with mild to moderate hypertension. [1988.09]
Controlled trial of enalapril and hydrochlorothiazide in 200 hypertensive patients. [1988.01]
Comparison of enalapril and hydrochlorothiazide in mild hypertension and changes in plasma lipid concentrations during therapy. [1988]
Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension. [1987.12]
Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions. [1987.12]
Combined action of enalapril or timolol with hydrochlorothiazide plus amiloride in hypertension. [1987]
Comparison of enalapril and thiazide diuretics in the elderly hypertensive patient. [1987]
Enalapril and hydrochlorothiazide as antihypertensive agents in the elderly. [1987]
Potentiation of the antihypertensive effect of enalapril by randomized addition of different doses of hydrochlorothiazide. [1985.12]
Well-designed clinical trials possibly related to Vaseretic (Enalapril / Hydrochlorothiazide)
Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension. [2004.10]
Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. [2004]
Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches. [2003.05]
Drug interaction of spirapril hydrochloride monohydrate and hydrochlorothiazide. A clinical study to compare the pharmacokinetics after administration of spirapril hydrochloride monohydrate tablets, hydrochlorothiazide tablets and fixed combination bi-layer tablets. [2003]
Are antihypertensive agents protective against dementia? A review of clinical and preclinical data. [2002.11]
The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. [2002.10.14]
Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. [2002.10]
Quality of life on randomized treatment for isolated systolic hypertension: results from the Syst-Eur Trial. [2002.10]
Effects of six anti-hypertensive medications on cognitive performance. [2002.08]
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension. [2002.06]
Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT). [2002.03]
Relationship between treatment-induced changes in left ventricular mass and blood pressure in black african hypertensive patients: results of the Baragwanath Trial. [2002.02.19]
Withdrawal from treatment in the Syst-Eur Trial. [2002.02]
Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial. [2001.12]
Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study. [2001.12]
Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens. [2001.10]
Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial. [2001.09]
Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH. [2001.07]
Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes. [2001.06.19]
Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. [2001.04.09]
Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. [2001.03]
Treatment of hypertension in the very old. [2000.11]
Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. [2000.09.05]
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). [2000.07.29]
Influence of diabetes and type of hypertension on response to antihypertensive treatment. [2000.05]
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. [1999.11.20]
[Antihypertensive treatment and prevention of dementia] [1999.09]
|
